Pharming Group N.V. Overview
Pharming Group N.V. (PHAR) has a P/E ratio of 66.79, above the Healthcare sector average of 19.01.
Get informed when a big investor buys or sells
+ Follow66.79
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for PHAR is 66.79. That is above the Healthcare sector average of 19.01. Investors often review this figure alongside Pharming Group N.V.'s historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, PHAR currently prints 66.79 for P/E ratio, while the sector average sits near 19.01. That is roughly 251.3% above the sector mean. Large gaps often invite a closer look at Pharming Group N.V.'s growth, margins, and balance sheet.
A P/E ratio of 66.79 for Pharming Group N.V. is not 'good' or 'bad' on its own. Compare it with the peer average (19.01) and with PHAR's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting PHAR's P/E ratio (66.79), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Pharming Group N.V.'s P/E ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
